Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia
Status:
Withdrawn
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Controlling blood sugar levels may be effective in preventing infections in
patients receiving chemotherapy for acute myeloid leukemia or acute lymphoblastic leukemia.
PURPOSE: This randomized phase I trial is studying how well controlling blood sugar levels
works in preventing infection in patients with acute myeloid leukemia or acute lymphoblastic
leukemia.
Phase:
Phase 3
Details
Lead Sponsor:
University of Medicine and Dentistry of New Jersey